RN Mobile Menu

Search form


Women's Health And Rheumatology

Can the "Formulary Police" Be Stopped?

Demands for prior approvals (PAs) have begun to spread, virus-like, from top-dollar biologics to familiar standards such as methotrexate. A quick survey by an Alabama rheumatologist reveals the additional high cost to practices of merely dealing with all those PAs. And who's practicing rheumatology now -- you or those health-plan clerks? What can be done? He offers a solution ...

Women's Health And Rheumatology


Thrombosis risk is increased in lupus, but not all patients are equal in this regard. This slide show summarizes the key points of a new systematic review on the topic that highlights risk assessment and treatment. Full text is available via hyperlinks in the captions.

Dating probably doesn't enter the conversation very often during visits with your lupus patients. Here, someone who has had more than her share of struggles with lupus describes trying to find someone to share that difficult life.

autoimmune disease pregnancy

In the third edition of #rheumjc, author (and Twitter regular) John Cush MD discusses a report from a summit on management of pregnancy and lactation in women with autoimmune and inflammatory diseases.

Pregnancy outcomes for women taking medications for rheumatic disease offer reassuring information. Also, details about forthcoming labeling changes for medications used during pregnancy, including biologics.

Pregnant patients concerned about taking painkillers for their rheumatic disease? Here's a quick summary of why the FDA thinks risks for miscarriage, neural tube defects and ADHD aren't yet well documented.

A review article in the Medical Letter highlights appropriate use and limitations of bisphosphonates, denosumab, and other osteoporosis treatment, along with the associated costs.


Subscribe to Women's Health And Rheumatology on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.